MyFinsight
Home
Blog
About
Short-term marketable
securities (amortized cost...
$174,382K
(12.72%↑ Y/Y)
Cash and cash
equivalents
$169,873K
(293.56%↑ Y/Y)
Accounts receivable, net
$49,513K
(11.81%↑ Y/Y)
Prepaid expenses and
other current assets
$16,298K
(44.29%↑ Y/Y)
Inventory
$10,497K
(24.92%↑ Y/Y)
Total current assets
$420,563K
(60.61%↑ Y/Y)
Goodwill
$118,972K
(0.00%↑ Y/Y)
Operating lease
right-of-use assets
$39,122K
(-9.73%↓ Y/Y)
Property and equipment,
net
$29,451K
(-28.26%↓ Y/Y)
Long-term marketable
securities (amortized cost...
$27,480K
(14.02%↑ Y/Y)
Restricted cash
$2,728K
(0.29%↑ Y/Y)
Other assets
$1,478K
(-26.58%↓ Y/Y)
Intangible assets, net
$884K
(-65.78%↓ Y/Y)
Total assets
$640,678K
(29.00%↑ Y/Y)
Total liabilities and
shareholders equity
$640,678K
(29.00%↑ Y/Y)
Total liabilities
$490,016K
(54.53%↑ Y/Y)
Total shareholders
equity
$150,662K
(-16.08%↓ Y/Y)
Convertible senior notes,
net
$334,876K
Total current
liabilities
$87,712K
(-4.81%↓ Y/Y)
Operating lease
liabilities, less current...
$66,800K
(-10.23%↓ Y/Y)
Deferred revenue, less
current portion
$608K
(-96.96%↓ Y/Y)
Other long-term
liabilities
$20K
(0.00%↑ Y/Y)
Total adaptive
biotechnologies corporation...
$142,914K
(-20.48%↓ Y/Y)
Noncontrolling interest
$7,748K
(4380.66%↑ Y/Y)
Accumulated deficit
-$1,423,144K
(-4.70%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$212K
(-390.41%↓ Y/Y)
Current portion of
deferred revenue
$53,255K
(-3.70%↓ Y/Y)
Accrued liabilities
$10,651K
(47.83%↑ Y/Y)
Accrued compensation
and benefits
$9,742K
(0.43%↑ Y/Y)
Current portion of
operating lease...
$8,823K
(-11.39%↓ Y/Y)
Accounts payable
$5,241K
(-24.13%↓ Y/Y)
Additional paid-in capital
$1,566,254K
(1.78%↑ Y/Y)
Common stock 0.0001 par
value, 340,000,000...
$16K
(6.67%↑ Y/Y)
Back
Back
Balance Sheet
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)
source: myfinsight.com